Professor Robert Perneczky
MD MBA
Neuroscience, School of Medicine and Population Health
Chair in Translational Dementia Research
r.perneczky@sheffield.ac.uk
+44 114 222 2295
+44 114 222 2295
ºù«Ӱҵ Institute for Translational Neuroscience (SITraN)
Full contact details
Professor Robert Perneczky
Neuroscience, School of Medicine and Population Health
ºù«Ӱҵ Institute for Translational Neuroscience (SITraN)
385a Glossop Road
ºù«Ӱҵ
S10 2HQ
Neuroscience, School of Medicine and Population Health
ºù«Ӱҵ Institute for Translational Neuroscience (SITraN)
385a Glossop Road
ºù«Ӱҵ
S10 2HQ
- Profile
-
- 2022-present: Professor of Translational Dementia Research, University of ºù«Ӱҵ, ºù«Ӱҵ, UK
- 2016-present: Professor/Head of Division of Old Age Psychiatry, Ludwig-Maximilians-University Munich/University Hospital LMU Munich, Germany
- 2016-present: PI/Research group leader, German Center for Neurodegenerative Diseases (DZNE) Munich, Germany
- 2012-2018: Reader in Dementia Research/Co-Head of Department/Consultant Psychiatrist, Imperial College London, School of Public Health, London, UK
- 2002-2013: Assistant doctor/consultant psychiatrist, Technical University Munich, Department of Psychiatry, Munich, Germany
- 2001: Qualification at Technical University Munich, Germany
- Research interests
-
- Alzheimer’s disease fluid biomarkers (blood, CSF, RNA)
- Neuroimaging (MRI, PET)
- Neuroepidemiology
- Pharmacological and non-pharmacological prevention/treatment of dementia
- Frontotemporal dementia, atypical Parkinson’s disease
- Healthcare preparedness in dementia
- Teaching interests
-
Old age psychiatry
- Professional activities and memberships
-
- Member of the German memory clinics network executive board
- Member of the University of ºù«Ӱҵ BRC executive board
- Member of the University of ºù«Ӱҵ, Neuroscience Flagship Institute executive board (Translational Neuroscience theme co-lead)
- Current Projects
- Mechanisms of Amyloid Clearance in Alzheimer’s disease and other neurodegenerative diseases (AmyClear), funded by VERUM Foundation, Germany and University of ºù«Ӱҵ BRC
- Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer’s disease (ActiGliA), funded by German Excellence Initiative and German Center for Neurodegenerative Disorders
- Non-pharmacological treatment of challenging behaviour in dementia, funded by Robert-Vogel-Foundation, Germany